DEFA14A: Supernus Pharmaceuticals Sets Date for Annual Stockholders Meeting

Supernus Pharmaceuticals will hold its annual stockholders meeting virtually on June 16, 2025, to vote on director elections, executive compensation, auditor ratification, and a stockholder proposal.

Summary

• Supernus Pharmaceuticals will hold its annual stockholders meeting on June 16, 2025.
• The meeting will be conducted virtually.
• Stockholders will vote on the election of two directors, the approval of executive compensation, the ratification of KPMG LLP as the independent auditor, and a stockholder proposal.
• The Board of Directors recommends voting FOR the director nominees, FOR Proposals 2 and 3, and AGAINST Proposal 4.
• Proxy materials are available online, and stockholders can request a paper copy by June 6, 2025.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, which is generally neutral in tone. It provides necessary information for shareholders to make informed decisions.

Positives

• The meeting will be held virtually, providing convenient access for stockholders.
• Stockholders have the opportunity to vote on key company matters, including director elections and executive compensation.
• Proxy materials are readily available online, and paper copies can be requested.

Future Outlook

The document outlines the agenda for the upcoming annual meeting, indicating the company's focus on corporate governance and shareholder engagement.

Management Comments

• The Board of Directors recommends a vote FOR all the nominees listed, FOR Proposals 2 and 3, and AGAINST Proposal 4.

Industry Context

This is a standard proxy statement related to an annual shareholder meeting, a routine event for publicly traded companies to address corporate governance matters.

Stakeholder Impact

• Shareholders are impacted by the proposals being voted on, including director elections and executive compensation.
• The outcome of the votes will influence the company's governance and direction.

Next Steps

• Stockholders should review the proxy materials and vote their shares before the meeting.
• The company will hold the annual meeting on June 16, 2025.

Key Dates

Keywords

stockholders meeting, proxy statement, annual meeting, Supernus Pharmaceuticals, corporate governance, voting, directors, executive compensation, KPMG, auditor